Emisiones de gases de efecto invernadero en la producción ganadera

Uno de los impactos ambientales provocados por el sector agropecuario es la emisión de gases de efecto invernadero (GEI). Los principales GEI emitidos desde el sector agropecuario son el dióxido de carbono (CO2), el óxido nitroso (N2O) y el metano (CH4). Estos gases elevaron mucho su concentración en el siglo XX. El sector ganadero es un importante emisor de GEI. La mayor contribución de N2O se produce a partir de las excretas animales, principalmente las líquidas, mientras que el CH4, se produce principalmente por fermentación entérica, siendo esta última la emisión de mayor significación en sistemas pecuarios. La investigación de emisiones GEI del sector agropecuarios está en un estado incipiente en Argentina. En las últimas décadas se registró un aumento en la demanda de productos procedentes del sector ganadero a nivel mundial, lo que se explica en parte por cambios en los patrones de consumo de alimentos de algunos sectores sociales. El Inventario Nacional de GEI muestra que un 49% de estas emisiones provienen del sector agropecuario, y dentro de este sector el 58% de los GEI son generados a partir de las distintas fuentes derivadas del ganado bajo pastoreo. Las estrategias de mitigación no necesariamente implican emitir menos GEI desde el sistema productivo, sino que pueden ser resultantes de una mayor productividad y, por ende, una menor cantidad de gas emitida por unidad de carne producida. Se resalta la importancia de contar con factores de emisión propios, medidos en nuestras condiciones y ambientes de producción.One of the environmental impacts caused by the agricultural sector is the emission of greenhouse gases (GHG). The main GHG emitted from the agricultural sector are carbon dioxide (CO2), nitrous oxide (N2O) and methane (CH4). These gases greatly increased their concentration in the 20th century. The livestock sector is an important GHG emitter. The greatest contribution of N2O is produced from animal excreta, mainly liquid excreta, while CH4 is mainly produced by enteric fermentation, the latter being the emission of greatest significance in livestock systems. The GHG emissions research of the agricultural sector is in an incipient state in Argentina. In recent decades there has been an increase in the demand for products from the livestock sector worldwide, which is partly explained by changes in the patterns of food consumption of some social sectors. The National GHG Inventory shows that 49% of these emissions come from the agricultural sector, and within this sector, 58% of GHG are generated from the different sources derived from livestock under grazing. Mitigation strategies do not necessarily imply emitting less GHG from the production system, but may be the result of higher productivity and, therefore, a lower amount of gas emitted per unit of meat produced. The importance of having our own emission factors, measured in our production conditions and environments, is highlighted.Instituto de SuelosFil: Costantini, Alejandro Oscar. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Suelos; Argentina. Universidad de Buenos Aires. Facultad de Agronomía, Cátedra de Edafología; ArgentinaFil: Perez, Mónica Gabriela. Universidad de Buenos Aires. Facultad de Agronomía, Cátedra de Edafología; ArgentinaFil: Busto, Mercedes. Universidad de Buenos Aires. Facultad de Agronomía, Cátedra de Edafología; ArgentinaFil: González, Franco Alexis. Universidad de Buenos Aires. Facultad de Agronomía, Cátedra de Edafología; ArgentinaFil: Cosentino, Vanina Rosa Noemi. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Suelos; Argentina. Universidad de Buenos Aires. Facultad de Agronomía. Cátedra de Fertilidad y Fertilizantes; ArgentinaFil: Romaniuk, Romina Ingrid. Instituto Nacional de Tecnología Agropecuaria (INTA). Instituto de Suelos; ArgentinaFil: Taboada, Miguel Angel. Instituto Nacional de Tecnología Agropecuaria (INTA). Instuto de Suelos; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentin

POR UNA CULTURA DE PAZ: UNA MIRADA DESDE LAS CIENCIAS DE LA CONDUCTA

En
 virtud
 de
 lo
 anterior,
 los
 estudiosos
 de
 las
 ciencias
 de
 la
 conducta
 
de
 la
 Universidad
Autónoma 
del
 Estado 
de 
México,

ante 
la
persistencia
 y 
proliferación
 de
 estos 
hechos
 en
 diversas
 partes
 del
Mundo
 y
 de
 nuestro 
país 
en 
particular, se
 convocó
 a
 los
 estudiosos
 interesados
 y
 a
 la
 sociedad
 en
 general
 a
 presentar
 trabajos
 para
 analizar,
 debatir
 y
 proponer
 estrategias
 de
 acción
 y
 dirección,
 que
 fortalezcan
 una
 convivencia y bienestar con sentido humanista para una cultura de paz. El
 presente
 texto
 es
 producto
 de 
esta convocatoria 
que
 recoge 
los
trabajos 
de 

los
 interesados 
en 
la
 temática,

 de
 diferentes 
países
(España,
Argentina,
Cuba,
Brasil,
Costa
 Rica
 y
 México)
 retomando
 con
 ello
 sus
 experiencias
 relativas
 al
 estudio,
 análisis,
 comprensión
 e
 instrumentación
 de
 la
 cultura
 de
 paz
 en
 los
 distintos
 ámbitos
 institucionales
 en
 los
 que
 participan:
 educativo,
 salud,
 penitenciario,
 social,
laboral,
familia,
alimentario,
psicológico,
por 
mencionar 
algunos.
 El
 presente
 libro,
 propicia
 un
 espacio
 de
 reflexión,
 diálogo
 y
 posicionamiento
 de
 las 
ciencias 
de 
la 
conducta
 para 
la 
apropiación,
análisis,
debate
 y 
propuestas 
que
 fortalezcan 
una
 cultura
 de 
paz
 a
través
 de 
la
 convivencia 
y
 el 
bienestar
 social 
con
 sentido 
humanista.
El
 sistema 
económico
 neoliberal
 y 
el 
proceso
 de 
globalización 
han
 contribuido
al
 logro
 de
 avances
 significativos
 en
 la
 ciencia
 y
 la
 tecnología,
 pero
 también
 han
 propiciado
 la
 polarización
 de
 las
 sociedades
 lo
 que
 ha
 impactado
 de
 manera
 negativa
 a
 la
 sociedad
 en
 su
 conjunto,
 pero
 en
 mayor
 medida
 a
 los grupos
 vulnerables. Dicha
 polarización
 ha
 traído
 consigo
 un
 desarrollo
 desigual
 del
 mundo
 que
 se
 expresa
 de
 diferentes
 maneras
 tanto
 en
 países
 desarrollados
 como
 en
 los
 llamados
 del
 tercer
 mundo,
 en
 donde
 no
 están
 satisfechas
 las
 necesidades
 humanas 
elementales
 de
 todos 
los
sectores 
de 
la 
población,
siempre 
falta 
algo. 
Si 
a
 esto 
le
 sumamos 
los
conflictos
 internacionales por
 diferentes
 motivos
 que
 enfrentan
 algunas
 naciones,
 una
 insuficiente
 cobertura
 educativa
 y
 de
 salud,

 desempleo
 y
 pobreza 
extrema,
 entre 
otras
 cosas; 
estamos
 frente
 a
retos 
de
 gran
 envergadura
 para
 los
 gobiernos,
 para
 los
 estudiosos
 y
 para
 la
 sociedad
 civil
 en
 general. Uno 
de 
los
 intentos
 para
 frenar 
y prevenir 
la
 agudización
 de 
estas 
problemáticas
 es
 la
 cultura 
de 
paz,
cuyo
 estudio
y propuestas 
han 
ido 
avanzando 
en 
diferentes
 sentidos 
y 
de 
manera 
favorable,
el 
tema 
está 
presente 
en 
diferentes 
Organismos
 Internacionales
 como
 la
 ONU,
 la
 UNESCO,
 la
 OCDE,
 El
 Banco
 Mundial,
 entre
 otros.
 Pero
 falta 
mucho 
por 
hacer.Universidad Autónoma del Estado de Méxic

Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial

Aims The objective of the Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT) was to determine whether aliskiren, a direct renin inhibitor, would improve post-discharge outcomes in patients with hospitalization for heart failure (HHF) with reduced ejection fraction. Pre-specified subgroup analyses suggested potential heterogeneity in post-discharge outcomes with aliskiren in patients with and without baseline diabetes mellitus (DM). Methods and results ASTRONAUT included 953 patients without DM (aliskiren 489; placebo 464) and 662 patients with DM (aliskiren 319; placebo 343) (as reported by study investigators). Study endpoints included the first occurrence of cardiovascular death or HHF within 6 and 12 months, all-cause death within 6 and 12 months, and change from baseline in N-terminal pro-B-type natriuretic peptide (NT-proBNP) at 1, 6, and 12 months. Data regarding risk of hyperkalaemia, renal impairment, and hypotension, and changes in additional serum biomarkers were collected. The effect of aliskiren on cardiovascular death or HHF within 6 months (primary endpoint) did not significantly differ by baseline DM status (P = 0.08 for interaction), but reached statistical significance at 12 months (non-DM: HR: 0.80, 95% CI: 0.64-0.99; DM: HR: 1.16, 95% CI: 0.91-1.47; P = 0.03 for interaction). Risk of 12-month all-cause death with aliskiren significantly differed by the presence of baseline DM (non-DM: HR: 0.69, 95% CI: 0.50-0.94; DM: HR: 1.64, 95% CI: 1.15-2.33; P < 0.01 for interaction). Among non-diabetics, aliskiren significantly reduced NT-proBNP through 6 months and plasma troponin I and aldosterone through 12 months, as compared to placebo. Among diabetic patients, aliskiren reduced plasma troponin I and aldosterone relative to placebo through 1 month only. There was a trend towards differing risk of post-baseline potassium ≥6 mmol/L with aliskiren by underlying DM status (non-DM: HR: 1.17, 95% CI: 0.71-1.93; DM: HR: 2.39, 95% CI: 1.30-4.42; P = 0.07 for interaction). Conclusion This pre-specified subgroup analysis from the ASTRONAUT trial generates the hypothesis that the addition of aliskiren to standard HHF therapy in non-diabetic patients is generally well-tolerated and improves post-discharge outcomes and biomarker profiles. In contrast, diabetic patients receiving aliskiren appear to have worse post-discharge outcomes. Future prospective investigations are needed to confirm potential benefits of renin inhibition in a large cohort of HHF patients without D

Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

Funder: Funder: Fundación bancaria ‘La Caixa’ Number: LCF/PR/PR16/51110003 Funder: Grifols SA Number: LCF/PR/PR16/51110003 Funder: European Union/EFPIA Innovative Medicines Initiative Joint Number: 115975 Funder: JPco-fuND FP-829-029 Number: 733051061Genetic discoveries of Alzheimer's disease are the drivers of our understanding, and together with polygenetic risk stratification can contribute towards planning of feasible and efficient preventive and curative clinical trials. We first perform a large genetic association study by merging all available case-control datasets and by-proxy study results (discovery n = 409,435 and validation size n = 58,190). Here, we add six variants associated with Alzheimer's disease risk (near APP, CHRNE, PRKD3/NDUFAF7, PLCG2 and two exonic variants in the SHARPIN gene). Assessment of the polygenic risk score and stratifying by APOE reveal a 4 to 5.5 years difference in median age at onset of Alzheimer's disease patients in APOE ɛ4 carriers. Because of this study, the underlying mechanisms of APP can be studied to refine the amyloid cascade and the polygenic risk score provides a tool to select individuals at high risk of Alzheimer's disease

New insights into the genetic etiology of Alzheimer's disease and related dementias

Characterization of the genetic landscape of Alzheimer's disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We performed a two-stage genome-wide association study totaling 111,326 clinically diagnosed/'proxy' AD cases and 677,663 controls. We found 75 risk loci, of which 42 were new at the time of analysis. Pathway enrichment analyses confirmed the involvement of amyloid/tau pathways and highlighted microglia implication. Gene prioritization in the new loci identified 31 genes that were suggestive of new genetically associated processes, including the tumor necrosis factor alpha pathway through the linear ubiquitin chain assembly complex. We also built a new genetic risk score associated with the risk of future AD/dementia or progression from mild cognitive impairment to AD/dementia. The improvement in prediction led to a 1.6- to 1.9-fold increase in AD risk from the lowest to the highest decile, in addition to effects of age and the APOE ε4 allele

Early mobilisation in critically ill COVID-19 patients: a subanalysis of the ESICM-initiated UNITE-COVID observational study

Background Early mobilisation (EM) is an intervention that may improve the outcome of critically ill patients. There is limited data on EM in COVID-19 patients and its use during the first pandemic wave. Methods This is a pre-planned subanalysis of the ESICM UNITE-COVID, an international multicenter observational study involving critically ill COVID-19 patients in the ICU between February 15th and May 15th, 2020. We analysed variables associated with the initiation of EM (within 72 h of ICU admission) and explored the impact of EM on mortality, ICU and hospital length of stay, as well as discharge location. Statistical analyses were done using (generalised) linear mixed-effect models and ANOVAs. Results Mobilisation data from 4190 patients from 280 ICUs in 45 countries were analysed. 1114 (26.6%) of these patients received mobilisation within 72 h after ICU admission; 3076 (73.4%) did not. In our analysis of factors associated with EM, mechanical ventilation at admission (OR 0.29; 95% CI 0.25, 0.35; p = 0.001), higher age (OR 0.99; 95% CI 0.98, 1.00; p ≤ 0.001), pre-existing asthma (OR 0.84; 95% CI 0.73, 0.98; p = 0.028), and pre-existing kidney disease (OR 0.84; 95% CI 0.71, 0.99; p = 0.036) were negatively associated with the initiation of EM. EM was associated with a higher chance of being discharged home (OR 1.31; 95% CI 1.08, 1.58; p = 0.007) but was not associated with length of stay in ICU (adj. difference 0.91 days; 95% CI − 0.47, 1.37, p = 0.34) and hospital (adj. difference 1.4 days; 95% CI − 0.62, 2.35, p = 0.24) or mortality (OR 0.88; 95% CI 0.7, 1.09, p = 0.24) when adjusted for covariates. Conclusions Our findings demonstrate that a quarter of COVID-19 patients received EM. There was no association found between EM in COVID-19 patients' ICU and hospital length of stay or mortality. However, EM in COVID-19 patients was associated with increased odds of being discharged home rather than to a care facility. Trial registration ClinicalTrials.gov: NCT04836065 (retrospectively registered April 8th 2021)

Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes

Across multiancestry groups, we analyzed Human Leukocyte Antigen (HLA) associations in over 176,000 individuals with Parkinson’s disease (PD) and Alzheimer’s disease (AD) versus controls. We demonstrate that the two diseases share the same protective association at the HLA locus. HLA-specific fine-mapping showed that hierarchical protective effects of HLA-DRB1*04 subtypes best accounted for the association, strongest with HLA-DRB1*04:04 and HLA-DRB1*04:07, and intermediary with HLA-DRB1*04:01 and HLA-DRB1*04:03. The same signal was associated with decreased neurofibrillary tangles in postmortem brains and was associated with reduced tau levels in cerebrospinal fluid and to a lower extent with increased Aβ42. Protective HLA-DRB1*04 subtypes strongly bound the aggregation-prone tau PHF6 sequence, however only when acetylated at a lysine (K311), a common posttranslational modification central to tau aggregation. An HLA-DRB1*04-mediated adaptive immune response decreases PD and AD risks, potentially by acting against tau, offering the possibility of therapeutic avenues

UM ESTUDO DE CASOS DE SUCESSO DAS PMEs NA COLÔMBIA: O CASO DO SETOR DA SAÚDE (publicado em espanhol)

El objetivo principal del estudio es identificar y analizar los factores que determinan el éxito de las PYMES en Colombia, tanto en lo referido a los factores internos como a lo externos, tomando como marco teórico de referencia la Teoría de Recursos y Capacidades y la Teoría Económica Institucional. Se realizó un estudio cualitativo profundizando en el análisis de cuatro empresas colombianas. Los resultados más relevantes indican que los factores que han determinado el éxito de estas pymes son el conocimiento y la experiencia del empresario, la reputación y el prestigio de la empresa, las medidas de apoyo y la especialización de la industria y la influencia de la comunidad en la cual desarrollan su actividad.The primary objective of this study is to identify and analyze the determining success factors of small and medium-sized enterprises (SMEs) in Colombia in terms of both internal and external factors employing the theories of resources and capabilities and institutional economics as the theoretical reference framework.  An qualitative study was conducted for an in-depth analysis of four different Colombian companies. The most relevant findings of this study reveal that the success determining factors of these SMEs are: the entrepreneur's knowledge and experience, the company's prestige and reputation, the supporting measures and specialization of the industry, and the influence of the communities in which their business is conducted.O objetivo principal do estudo é identificar e analisar os fatores que determinam o sucesso entre as PMEs na Colômbia, tanto no que se refere aos fatores internos como aos externos, tomando como marco teórico de referência da Teoria de Recursos e Capacidades e a Teoria Económica Institucional. Foi realizado um estudo qualitativo aprofundado na análise de quatro empresas colombianas. Os resultados mais relevantes indicam que os fatores que determinaram o sucesso dessas PMEs são o conhecimento e a experiencia do empresário, a reputação e o prestígio da empresa, as medidas de apoio e a especialização da indústria e a influência da comunidade em que desenvolvem a sua atividade

Crea

La empresa crea sería una línea de la ya constituida Eurosur que maneja madera de árbol. Crea se espera que sea de gran acogida en el mercado, gracias a la aceptación de sus productos por su calidad y cumplimiento. También yacería como una empresa vallecaucana dedicada a la fabricación, reparación, distribución de artículos deportivos en madera plástica, mueble y artículos para decoración de interiores, tanto para residencias como para locales comerciales